SDCCAG3 Inhibitors
Chemical inhibitors of SDCCAG3 can influence its activity through various mechanisms, primarily by targeting different kinases that are crucial for the protein's functional role in cellular signaling pathways. Staurosporine, a well-known protein kinase inhibitor, can impinge on the kinase activity that SDCCAG3 depends on for its function. This inhibition can curtail the phosphorylation events necessary for SDCCAG3's role in signal transduction. Similarly, Bisindolylmaleimide I focuses its action on protein kinase C (PKC), and by disrupting PKC-dependent pathways, it can diminish the functional activity of SDCCAG3. LY294002 and Wortmannin, both potent inhibitors of PI3K, can dampen the downstream signaling of AKT pathways, thereby affecting SDCCAG3's activity. By impeding PI3K, these inhibitors prevent the propagation of signals that are vital for SDCCAG3's operations within the cell.
Furthermore, Rapamycin, by inhibiting mTOR, can constrain the cell growth and proliferation signals that SDCCAG3 may be involved in. The inhibition of mTOR signaling pathways can lead to a reduction in SDCCAG3's participation in these cellular processes. PD98059 and U0126, which selectively inhibit MEK1/2, can also suppress the activation of the ERK pathway. This action results in a decreased signaling cascade that is essential for SDCCAG3's activity. SB203580, by targeting p38 MAP kinase, can intervene in cellular responses where SDCCAG3 is implicated, further inhibiting its activity. SP600125 and Lestaurtinib, inhibitors of JNK and JAK2 kinases respectively, can alter stress, inflammatory responses, and other critical signaling pathways associated with SDCCAG3. Additionally, PP2, as an inhibitor of Src family tyrosine kinases, disrupts essential signaling pathways required for SDCCAG3's function. These chemical inhibitors, through their targeted action on specific kinases, can effectively curtail the functional role of SDCCAG3 in various cellular signaling processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. SDCCAG3's function can be inhibited by staurosporine through the inhibition of kinase activity that SDCCAG3 relies upon for its functional role in cellular signaling processes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC). It can inhibit SDCCAG3 by impeding PKC-dependent signaling pathways that are essential for the full functional activity of SDCCAG3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, a kinase involved in multiple signaling pathways. By inhibiting PI3K, LY294002 can suppress the downstream signaling required for SDCCAG3 activity, leading to functional inhibition of SDCCAG3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation. By inhibiting mTOR signaling pathways, Rapamycin can disrupt processes that are essential for the functional activity of SDCCAG3, leading to its inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which can prevent the activation of the ERK pathway. By inhibiting MEK, PD98059 can disrupt the ERK signaling pathway that SDCCAG3 may depend on, thus inhibiting the functional activity of SDCCAG3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase. Inhibition of p38 MAPK can lead to the disruption of cellular responses where SDCCAG3 is functionally involved, thereby inhibiting the activity of SDCCAG3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which can affect stress and inflammatory responses. By inhibiting JNK-mediated signaling, SP600125 can inhibit the functional role of SDCCAG3 that is associated with these cellular processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1 and MEK2. Inhibition of these kinases can lead to a decrease in ERK pathway signaling, which is essential for the functional activity of SDCCAG3, thus inhibiting SDCCAG3. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, Wortmannin can decrease the signaling through the AKT pathway, which is necessary for the functional activity of SDCCAG3, leading to its inhibition. | ||||||
SL-327 | 305350-87-2 | sc-200685 sc-200685A | 1 mg 10 mg | $107.00 $332.00 | 7 | |
SL327 is a selective inhibitor of MEK. By inhibiting MEK, SL327 can reduce ERK signaling, which is necessary for the functional activity of SDCCAG3, leading to its inhibition. | ||||||